Radioprotection for Patients and Staff during BNCT at the HFR Petten

The European clinical trial (EORTC 11961) of BNCT for glioblastoma patients started at Petten in October 1997. The treatment of a patient and the potential exposure of personnel to ionising radiation require by the national Nuclear Energy Law, that the JRC (as licence holder of the HFR) must ensure that radiological protection and monitoring of all personnel, including external staff, is provided and that the correct radio-protection measures are taken and followed.